Verrica Pharmaceuticals Inc. (VRCA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Verrica Pharmaceuticals I...

    NASDAQ: VRCA · Real-Time Price · USD
    4.67
    0.13 (2.86%)
    At close: Oct 03, 2025, 3:59 PM

    Verrica Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -76.58M -67M -24.49M -35.08M
    Depreciation & Amortization
    		 1.27M 836K 718K 472K
    Stock-Based Compensation
    		 7.16M 14.38M 4.99M 6.05M
    Other Working Capital
    		 -1.74M 11.59M -1.46M -1.03M
    Other Non-Cash Items
    		 5.19M 3.35M 1.93M 1.44M
    Deferred Income Tax
    		 n/a n/a n/a 66K
    Change in Working Capital
    		 2.03M 9.86M -1.8M -535K
    Operating Cash Flow
    		 -60.93M -38.58M -18.65M -27.58M
    Capital Expenditures
    		 -27K -362K -302K -883K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a -4.49M -68.91M
    Sales Maturities Of Investments
    		 n/a n/a 59.01M 69M
    Other Investing Acitivies
    		 8K n/a -180K -201K
    Investing Cash Flow
    		 -19K -362K 54.04M -998K
    Debt Repayment
    		 -2.06M 44.08M -43.75M 4.97M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 155K -169K -17K 558K
    Financial Cash Flow
    		 37.73M 74.21M -16.87M 33.65M
    Net Cash Flow
    		 -23.22M 35.27M 18.52M 5.07M
    Free Cash Flow
    		 -60.95M -38.94M -18.95M -28.46M

    Add to Watchlist